Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Metabolomics for Improved Screening of Cystic Fibrosis: Better Diagnostics Without Carrier Identification

FY 2014-15

Summary
Cystic fibrosis (CF) is one of the most common disabling genetic diseases in Canada that reduces life expectancy due to progressive lung failure and chronic malnutrition. Early detection and treatment intervention is critical for CF patients to lead longer and healthier lives while reducing healthcare costs. Newborn screening for CF currently relies on a two-tiered approach that includes genetic testing, which is limited by a high rate of false-positive screen results that identifies unaffected carriers who do not express the disease. CF screening also detects infants with atypical or mild disease variants whose clinical diagnoses are unclear. The main objective of this proposal is to discover a panel of metabolites from dried blood spots or sweat that will serve as novel biomarkers to improve the screening, diagnosis and prognosis of the CF disease spectrum. Since metabolites represent “real-world” products of genes that reflect clinical outcomes, comprehensive metabolite profiling (i.e., metabolomics) will be used to identify CF-specific biochemical signatures associated with affected infants without carrier identification. State-of-the-art capillary electrophoresis- mass spectrometry technology will be applied for novel biomarker discovery. It is anticipated that this research will transform the screening practice of CF, avoiding the ethical concerns of widespread genetic testing while providing clinicians with new diagnostic information for better treatment decisions.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
331274
Name
Nemr Carine
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Metabolomics for Improved Screening of Cystic Fibrosis: Better Diagnostics Without Carrier Identification
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biomarker Identification; Blood; Capillary Electrophoresis; Cystic Fibrosis; Mass Spectrometry; Metabolite Profiling; Method Development; Newborn Screening; Phenotype; Sweat
Abstract
Cystic fibrosis (CF) is one of the most common disabling genetic diseases in Canada that reduces life expectancy due to progressive lung failure and chronic malnutrition. Early detection and treatment intervention is critical for CF patients to lead longer and healthier lives while reducing healthcare costs. Newborn screening for CF currently relies on a two-tiered approach that includes genetic testing, which is limited by a high rate of false-positive screen results that identifies unaffected carriers who do not express the disease. CF screening also detects infants with atypical or mild disease variants whose clinical diagnoses are unclear. The main objective of this proposal is to discover a panel of metabolites from dried blood spots or sweat that will serve as novel biomarkers to improve the screening, diagnosis and prognosis of the CF disease spectrum. Since metabolites represent “real-world” products of genes that reflect clinical outcomes, comprehensive metabolite profiling (i.e., metabolomics) will be used to identify CF-specific biochemical signatures associated with affected infants without carrier identification. State-of-the-art capillary electrophoresis- mass spectrometry technology will be applied for novel biomarker discovery. It is anticipated that this research will transform the screening practice of CF, avoiding the ethical concerns of widespread genetic testing while providing clinicians with new diagnostic information for better treatment decisions.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Nemr, Carine
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~